Serum Institute of India is a manufacturer of immunobiological drugs including vaccines in India. It was founded by Cyrus Poonawalla in 1966. The company is a subsidiary of the holding company Poonawalla Investment and Industries. Read More
Novavax on Tuesday announced the first emergency use authorization of its COVID-19 vaccine for adolescents falling in the age bracket of 12-18 years in India. ...
Since most of the buyers are depending upon loans from the banks and financial institutions, timely possession has become a critical factor in the realty sector. ...
BSE (560961) & NSE (VIKASECO) listed Vikas Ecotech Ltd. an emerging player in the global arena of the high end specialty chemicals players, offering eco-friendly and technologically superior products to the world has announced that on persistence and ...
The Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation (EUA) to Serum Institute of India's (SII) COVID-19 vaccine Covovax for adults and for children above the age of 12 years. ...
New Delhi, Feb 18 InterGlobe Aviation's non-executive, non-independent director and co-founder Rakesh Gangwal on Friday tendered his resignation ... ...
Padma Bhushan-awardee and industrialist Cyrus Poonawala on Monday said Serum Institute of India (SI) provided COVID-19 vaccine at "the cost of a cup of tea" and saved nearly two-thirds infant population in the world. ...